• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

  • By Adam Feuerstein
  • Dec 19, 2014 9:02 AM EST
Stock Market Today - Corporate Profitability Trends, Global Marco Economy
INVESTING

Jim Cramer on the Stock Market: You Have to Love Biotech

  • By Jim Cramer
  • Dec 3, 2014 12:29 PM EST
Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
MARKETS

Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs

  • By Keris Alison Lahiff
  • Dec 2, 2014 4:30 PM EST
Stocks Inch Higher as Yellen Eases Markets Into Drop in 'Patient' Phrasing
MARKETS

Stocks Hover Near Highs as Oil Backtracks From Monday Bounce

  • By Keris Alison Lahiff
  • Dec 2, 2014 2:23 PM EST
Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
MARKETS

Stocks Gain as Construction Spending Expands, Global Stimulus Talk Heats Up

  • By Keris Alison Lahiff
  • Dec 2, 2014 10:50 AM EST
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Avanir Fetches $3.5B From Japan's Otsuka for Reformulated Cough Syrup

  • By Adam Feuerstein
  • Dec 2, 2014 9:13 AM EST
Stocks Inch Higher as Yellen Eases Markets Into Drop in 'Patient' Phrasing
MARKETS

Stock Futures Rise as Wall Street Recovers From Tech, Retail Selloff

  • By Keris Alison Lahiff
  • Dec 2, 2014 9:09 AM EST
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

AVANIR Pharmaceuticals (AVNR) Is Today's Pre-Market Mover With Heavy Volume Stock

  • By Jamie Hodge
  • Dec 2, 2014 7:56 AM EST
Endo Int'l. (ENDP) Stock Declined Despite Earnings Beat
MARKETS

Avanir Pharmaceuticals (AVNR) Stock Surges Today on $3.54 Billion Otsuka Deal

  • By Tedd Cohen
  • Dec 2, 2014 7:54 AM EST
Stocks Climb in Choppy Session as GE Real Estate Deal Drives Dow
STOCKS

December 2 Premarket Briefing: 10 Things You Should Know

  • By Joseph Woelfel
  • Dec 2, 2014 6:54 AM EST
Endo Int'l. (ENDP) Stock Declined Despite Earnings Beat
MARKETS

Avanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application Feedback

  • By Andrew Meola
  • Nov 7, 2014 11:25 AM EST
What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Will Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action?

  • By Sebastian Silva
  • Nov 4, 2014 8:52 AM EST
Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Super Important Biotech and Drug Stock Events for November

  • By Adam Feuerstein
  • Nov 3, 2014 8:24 AM EST
AirMedia Group (AMCN) In A Perilous Reversal
MARKETS

Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR)

  • By Scott Olson
  • Oct 31, 2014 10:19 AM EDT
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock

  • By Scott Olson
  • Oct 30, 2014 4:19 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

  • By Adam Feuerstein
  • Oct 17, 2014 7:05 AM EDT
Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock

  • By Scott Olson
  • Oct 13, 2014 4:17 PM EDT
HCA Holdings (HCA) Stock Gains After Supreme Court Ruling
MARKETS

How Will Public Offering Pricing Affect Avanir Pharmaceuticals (AVNR) Stock Today?

  • By Andrew Meola
  • Sep 24, 2014 10:10 AM EDT
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

AVANIR Pharmaceuticals (AVNR) Down In Post-Market Activity

  • By Marissa Goodbody
  • Sep 22, 2014 5:03 PM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders

  • By Brian Hamilton
  • Sep 18, 2014 10:30 AM EDT
Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today

  • By Scott Olson
  • Sep 16, 2014 9:45 AM EDT
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

  • By Jonas Elmerraji
  • Sep 16, 2014 9:16 AM EDT
Newmont Mining (NEM) Stock Declining Amid Falling Gold Prices
MARKETS

Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today

  • By Andrew Meola
  • Sep 15, 2014 4:06 PM EDT
Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
INVESTING

Avanir's Over-Priced Cough Syrup Touted for Role in Alzheimer's Agitation

  • By Adam Feuerstein
  • Sep 15, 2014 10:19 AM EDT
Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

AVANIR Pharmaceuticals (AVNR) Is Today's Pre-Market Mover With Heavy Volume Stock

  • By Jamie Hodge
  • Sep 15, 2014 9:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.